News
Gästebuch
Videos
VoiceOver
Live Cam
Fun
Live TV
Ausflüge
Weingarten
London
Blaubeuren
Isny
Langenargen
Lindau
Bregenz
Ulm
Kontakt
Impressum
Deutsch
de
English
en
Français
fr
News
Gästebuch
Videos
VoiceOver
Live Cam
Fun
Live TV
Ausflüge
Weingarten
London
Blaubeuren
Isny
Langenargen
Lindau
Bregenz
Ulm
Kontakt
Impressum
Deutsch
de
English
en
Français
fr
EKM Einführung in die klinische Medizin
GTE Historische Entwicklung der Medizin
Medizin
Button
Aktuelle Forschungsergebnisse aus verschiedenen Gebieten der Humanmedizin
Robert Koch Institut
Medscape
Pub Med
Research Square
Ärztekammer BW
Kardiologie
MAR
10
ANGPTL3-lowering strategies to address residual cardiovascular risk
By:
Farzahna Mohamed
on
MAR
10
Nature Reviews Cardiology, Published online: 10 March 2026; doi:10.1038/s41569-026-01273-zANGPTL3-lowering strategies to address residual cardiovascular risk
Mehr lesen >>
MAR
10
Antiphospholipid antibodies and cardiovascular thrombosis
By:
Sina Rashedi
on
MAR
10
Nature Reviews Cardiology, Published online: 10 March 2026; doi:10.1038/s41569-026-01269-9Antiphospholipid antibodies (aPL) are associated with an elevated risk of thromboembolic events in patients with antiphospholipid syndrome and, increasingly, in those without previous thrombosis. In this Review, Bikdeli and colleagues discuss the clinical relevance of aPL seropositivity in predicting the risk of thrombotic cardiovascular events, summarize potential management strategies and identify key knowledge gaps that warrant further research.
Mehr lesen >>
MAR
03
The City Heartbeat Index as a benchmarking tool for urban cardiovascular health
By:
Amanda Stucke
on
MAR
03
Nature Reviews Cardiology, Published online: 03 March 2026; doi:10.1038/s41569-026-01267-xCities are dense population hubs where lifestyle, environmental and socioeconomic factors influence health outcomes, including morbidity and mortality secondary to cardiovascular disease. The City Heartbeat Index offers a city-level benchmarking framework that enables policy leaders to assess and implement the prevention and management of cardiovascular disease in urban environments.
Mehr lesen >>
MAR
02
Author Correction: The effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure
By:
Wolfram Doehner
on
MAR
02
Nature Reviews Cardiology, Published online: 02 March 2026; doi:10.1038/s41569-026-01272-0Author Correction: The effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure
Mehr lesen >>
FEB
27
Understanding atrial failure: from diagnosis to clinical implications
By:
Bryce Alexander
on
FEB
27
Nature Reviews Cardiology, Published online: 27 February 2026; doi:10.1038/s41569-026-01266-yAtrial failure is an emerging clinical syndrome that results from an underlying atrial cardiomyopathy and manifests with clinical symptoms. In this Review, Baranchuk and colleagues detail the pathophysiological mechanisms, clinical phenotypes and multimodality imaging of atrial failure as well as emerging therapeutic strategies to reverse atrial remodelling.
Mehr lesen >>
FEB
24
The effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure
By:
Wolfram Doehner
on
FEB
24
Nature Reviews Cardiology, Published online: 24 February 2026; doi:10.1038/s41569-026-01268-wThe effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure
Mehr lesen >>
FEB
24
Reply to: ‘The effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure’
By:
Navin Suthahar
on
FEB
24
Nature Reviews Cardiology, Published online: 24 February 2026; doi:10.1038/s41569-026-01270-2Reply to: ‘The effects of skeletal muscle and adipose tissue on outcomes in patients with heart failure’
Mehr lesen >>
FEB
23
HFpEF and MASLD: converging mechanisms and clinical implications
By:
Federico Capone
on
FEB
23
Nature Reviews Cardiology, Published online: 23 February 2026; doi:10.1038/s41569-026-01257-zSchiattarella and colleagues propose a framework linking heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease as interconnected syndromes rather than coincidental comorbidities. The authors delineate shared metabolic, inflammatory and endocrine drivers and propose a shift towards coordinated strategies and integrated clinical algorithms to improve prevention, risk stratification, early detection and co-management of these disorders.
Mehr lesen >>
Weitere Beiträge
Klinische Onkologie
MAR
10
Author Correction: Innovative approaches for lung cancer screening and interception
By:
Jianjun Zhang
on
MAR
10
Nature Reviews Clinical Oncology, Published online: 10 March 2026; doi:10.1038/s41571-026-01140-3Author Correction: Innovative approaches for lung cancer screening and interception
Mehr lesen >>
MAR
10
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
By:
Joan Choo
on
MAR
10
Nature Reviews Clinical Oncology, Published online: 10 March 2026; doi:10.1038/s41571-026-01134-1The development of immune checkpoint inhibitors and novel targeted therapies and the incorporation of these agents into first-line therapy for biomarker-selected patients with metastatic gastric cancer has improved outcomes. Nonetheless, many challenges remain, including both primary and acquired resistance as well as a lack of relevant biomarkers in certain subgroups. In this Review, the authors describe the current approach to first-line therapy for patients with metastatic gastric cancer as well as emerging approaches that might improve the standard of care in the coming years.
Mehr lesen >>
MAR
09
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown
By:
Edoardo Mannucci
on
MAR
09
Nature Reviews Clinical Oncology, Published online: 09 March 2026; doi:10.1038/s41571-026-01135-0Glucagon-like peptide 1 receptor agonists (GLP1RAs) are widely used by individuals with type 2 diabetes mellitus (T2DM) and/or obesity. Both of these conditions are also associated with an increased risk of certain cancers, and this risk might be ameliorated following intentional weight loss, which can consistently be achieved with GLP1RAs. Conversely, several reports have suggested an increased risk of certain cancers, such as medullary or non-medullary thyroid cancer and pancreatic cancer among those receiving GLP1RAs. In this Review, the authors evaluate these competing risks and the underlying evidence as well as highlighting areas in which evidence is limited and more research will be needed in order to definitively understand the implications of GLP1RAs for cancer risk.
Mehr lesen >>
MAR
04
The changing landscape of oncology clinical trials in Latin America
By:
Andreia Cristina de Melo
on
MAR
04
Nature Reviews Clinical Oncology, Published online: 04 March 2026; doi:10.1038/s41571-026-01137-yAlthough oncology advances stem from clinical research, <5% of global cancer trials actively recruit patients in Latin America. Herein, I discuss why expanding inclusive trial designs and fostering multisector partnerships are essential to reduce disparities and improve the role of Latin America in global oncology research. I present examples such as the recent regulatory reforms in Brazil that aim to accelerate study approvals, as well as collaborative initiatives between local and international research groups to further strengthen clinical trial capacity.
Mehr lesen >>
MAR
03
Lisocabtagene maraleucel has high efficacy in R/R MZL
By:
David Killock
on
MAR
03
Nature Reviews Clinical Oncology, Published online: 03 March 2026; doi:10.1038/s41571-026-01138-xLisocabtagene maraleucel has high efficacy in R/R MZL
Mehr lesen >>
MAR
03
Perioperative approaches for patients with biliary tract cancer
By:
Anudari Zorigtbaatar
on
MAR
03
Nature Reviews Clinical Oncology, Published online: 03 March 2026; doi:10.1038/s41571-026-01130-5Cholangiocarcinomas, comprising intrahepatic, extrahepatic and perihilar subtypes as well as gallbladder cancer, are a heterogeneous group of malignancies that necessitates a personalized approach to both surgery and systemic therapy. In this Review, the authors describe progress in the development of personalized perioperative therapy strategies as well as the most promising future research directions in this diverse and often difficult-to-treat group of cancers.
Mehr lesen >>
MAR
02
Enfortumab vedotin plus pembrolizumab effective in patients with resectable bladder cancer
By:
Peter Sidaway
on
MAR
02
Nature Reviews Clinical Oncology, Published online: 02 March 2026; doi:10.1038/s41571-026-01139-wEnfortumab vedotin plus pembrolizumab effective in patients with resectable bladder cancer
Mehr lesen >>
FEB
24
Translating ferroptosis into oncology: challenges, opportunities and future directions
By:
Rui Kang
on
FEB
24
Nature Reviews Clinical Oncology, Published online: 24 February 2026; doi:10.1038/s41571-026-01128-zDespite substantial interest in exploiting ferroptosis — an iron-mediated, lipid peroxidation-driven form of cell death — for cancer therapy, progress towards clinical translation has been limited. This comprehensive Review describes the major barriers that have restricted ferroptosis-based therapeutic development as well as emerging opportunities presented by new ferroptosis-inducing agents, biomarker-guided patient selection and rational combination treatments.
Mehr lesen >>
Weitere Beiträge
Endokrinologie
MAR
11
Peritumoural adipose tissue protects colorectal cancer from immune attack
By:
Olivia Tysoe
on
MAR
11
Nature Reviews Endocrinology, Published online: 11 March 2026; doi:10.1038/s41574-026-01244-xPeritumoural adipose tissue protects colorectal cancer from immune attack
Mehr lesen >>
MAR
09
Living with type 1 diabetes mellitus with Black heritage: my personal journey
By:
Daniel Newman
on
MAR
09
Nature Reviews Endocrinology, Published online: 09 March 2026; doi:10.1038/s41574-026-01242-zFor nearly three decades, my life has consisted of insulin injections, monitoring of glucose levels and emotional, mental and physical labour. Here, I share my experience of being a Black person living with type 1 diabetes mellitus, including cultural and systemic challenges that affected my access to the care I was entitled to.
Mehr lesen >>
MAR
09
Hyperinsulinaemia as a cause of obesity and cardiometabolic diseases
By:
Nicola Guess
on
MAR
09
Nature Reviews Endocrinology, Published online: 09 March 2026; doi:10.1038/s41574-026-01240-1This Review outlines the potential role of hyperinsulinaemia as an independent driver of obesity and obesity-related conditions. Evidence regarding the potential causes of hyperinsulinaemia are summarized, and key research gaps are highlighted.
Mehr lesen >>
MAR
03
The gut microbiome and ageing trajectories: mechanisms and clinical implications
By:
Andrea Ticinesi
on
MAR
03
Nature Reviews Endocrinology, Published online: 03 March 2026; doi:10.1038/s41574-026-01236-xThe gut microbiome varies highly between individuals and has a substantial contribution to long-term health. This Review examines the effect of the gut microbiome on ageing and frailty risk, including potential therapies to modify gut microbiome composition to promote healthy ageing.
Mehr lesen >>
FEB
27
Dual benefits of HIF activation
By:
Claire Greenhill
on
FEB
27
Nature Reviews Endocrinology, Published online: 27 February 2026; doi:10.1038/s41574-026-01241-0Dual benefits of HIF activation
Mehr lesen >>
FEB
25
The genetics behind thyroid disease
By:
Senegal Carty
on
FEB
25
Nature Reviews Endocrinology, Published online: 25 February 2026; doi:10.1038/s41574-026-01238-9The genetics behind thyroid disease
Mehr lesen >>
FEB
16
The long-overlooked effect of hypothyroidism on the global burden of non-communicable diseases
By:
Leonidas H. Duntas
on
FEB
16
Nature Reviews Endocrinology, Published online: 16 February 2026; doi:10.1038/s41574-026-01235-yThis Comment highlights the multiple effects of hypothyroidism and its strong connection to non-communicable diseases (NCDs), serving as a call to action for a global alliance to recognize hypothyroidism as a modifiable risk factor for NCDs. Additionally, it emphasizes the urgent need to raise awareness and improve thyroid management to address the growing burden of NCDs.
Mehr lesen >>
FEB
10
Making a droplet: the adipogenin–seipin complex at work
By:
Daniel Tews
on
FEB
10
Nature Reviews Endocrinology, Published online: 10 February 2026; doi:10.1038/s41574-026-01234-zAdipogenin is a microprotein expressed in adipose tissue. Previous studies have suggested its role in lipid storage, yet the underlying molecular mechanisms have been unclear. A recent study published in Science presents evidence that adipogenin forms complexes with seipin, a protein that is essential for lipid droplet formation in adipocytes, thereby modulating lipid storage.
Mehr lesen >>
Weitere Beiträge
MAR
11
Peritumoural adipose tissue protects colorectal cancer from immune attack
By:
Olivia Tysoe
on
MAR
11
Nature Reviews Endocrinology, Published online: 11 March 2026; doi:10.1038/s41574-026-01244-xPeritumoural adipose tissue protects colorectal cancer from immune attack
Mehr lesen >>
MAR
09
Living with type 1 diabetes mellitus with Black heritage: my personal journey
By:
Daniel Newman
on
MAR
09
Nature Reviews Endocrinology, Published online: 09 March 2026; doi:10.1038/s41574-026-01242-zFor nearly three decades, my life has consisted of insulin injections, monitoring of glucose levels and emotional, mental and physical labour. Here, I share my experience of being a Black person living with type 1 diabetes mellitus, including cultural and systemic challenges that affected my access to the care I was entitled to.
Mehr lesen >>
MAR
09
Hyperinsulinaemia as a cause of obesity and cardiometabolic diseases
By:
Nicola Guess
on
MAR
09
Nature Reviews Endocrinology, Published online: 09 March 2026; doi:10.1038/s41574-026-01240-1This Review outlines the potential role of hyperinsulinaemia as an independent driver of obesity and obesity-related conditions. Evidence regarding the potential causes of hyperinsulinaemia are summarized, and key research gaps are highlighted.
Mehr lesen >>
MAR
03
The gut microbiome and ageing trajectories: mechanisms and clinical implications
By:
Andrea Ticinesi
on
MAR
03
Nature Reviews Endocrinology, Published online: 03 March 2026; doi:10.1038/s41574-026-01236-xThe gut microbiome varies highly between individuals and has a substantial contribution to long-term health. This Review examines the effect of the gut microbiome on ageing and frailty risk, including potential therapies to modify gut microbiome composition to promote healthy ageing.
Mehr lesen >>
FEB
27
Dual benefits of HIF activation
By:
Claire Greenhill
on
FEB
27
Nature Reviews Endocrinology, Published online: 27 February 2026; doi:10.1038/s41574-026-01241-0Dual benefits of HIF activation
Mehr lesen >>
FEB
25
The genetics behind thyroid disease
By:
Senegal Carty
on
FEB
25
Nature Reviews Endocrinology, Published online: 25 February 2026; doi:10.1038/s41574-026-01238-9The genetics behind thyroid disease
Mehr lesen >>
FEB
16
The long-overlooked effect of hypothyroidism on the global burden of non-communicable diseases
By:
Leonidas H. Duntas
on
FEB
16
Nature Reviews Endocrinology, Published online: 16 February 2026; doi:10.1038/s41574-026-01235-yThis Comment highlights the multiple effects of hypothyroidism and its strong connection to non-communicable diseases (NCDs), serving as a call to action for a global alliance to recognize hypothyroidism as a modifiable risk factor for NCDs. Additionally, it emphasizes the urgent need to raise awareness and improve thyroid management to address the growing burden of NCDs.
Mehr lesen >>
FEB
10
Making a droplet: the adipogenin–seipin complex at work
By:
Daniel Tews
on
FEB
10
Nature Reviews Endocrinology, Published online: 10 February 2026; doi:10.1038/s41574-026-01234-zAdipogenin is a microprotein expressed in adipose tissue. Previous studies have suggested its role in lipid storage, yet the underlying molecular mechanisms have been unclear. A recent study published in Science presents evidence that adipogenin forms complexes with seipin, a protein that is essential for lipid droplet formation in adipocytes, thereby modulating lipid storage.
Mehr lesen >>
Weitere Beiträge
GI und Hepatologie
MAR
11
Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts
By:
Enkhtuul Batbold
on
MAR
11
Nature Reviews Gastroenterology & Hepatology, Published online: 11 March 2026; doi:10.1038/s41575-026-01186-9The elimination of hepatitis B will not be achieved through innovation alone. It requires dismantling the structural inequities that have long constrained who leads, funds and benefits from global hepatitis B research.
Mehr lesen >>
MAR
09
Physical activity and the gut
By:
Katrina Ray
on
MAR
09
Nature Reviews Gastroenterology & Hepatology, Published online: 09 March 2026; doi:10.1038/s41575-026-01192-xPhysical activity and the gut
Mehr lesen >>
MAR
06
ECCO’26
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01194-9ECCO’26
Mehr lesen >>
MAR
06
Long-term data for ileocaecal resection for ileal Crohn’s disease
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01193-wLong-term data for ileocaecal resection for ileal Crohn’s disease
Mehr lesen >>
MAR
06
HIV-associated gut microbiome influences gut mucosal immunity
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01191-yHIV-associated gut microbiome influences gut mucosal immunity
Mehr lesen >>
MAR
04
Microplastics and nanoplastics in the human gut: from signals to standards
By:
Brian D. Deng
on
MAR
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 March 2026; doi:10.1038/s41575-026-01185-wThe gastrointestinal tract is a critical interface for microplastic and nanoplastic exposure, yet causal links to health outcomes remain uncertain. We outline current methodological challenges and provide a list of minimum standards for rigorous study design, standardized reporting and careful attention to interpretations to distinguish mechanism from signals.
Mehr lesen >>
MAR
02
Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut
By:
Shan Liu
on
MAR
02
Nature Reviews Gastroenterology & Hepatology, Published online: 02 March 2026; doi:10.1038/s41575-026-01178-9Metabolites are important mediators of metabolism at the cellular and organismal levels. This Review explores the concept of metabotherapy, harnessing metabolites to prevent and treat gastrointestinal disorders, providing insights into metabolite classifications and their pathophysiological mechanisms in health and disease and mapping their potential as therapeutic targets.
Mehr lesen >>
FEB
23
Hepatitis C elimination: is it time to redefine the goals?
By:
Yasser Fouad
on
FEB
23
Nature Reviews Gastroenterology & Hepatology, Published online: 23 February 2026; doi:10.1038/s41575-026-01184-xDirect-acting antiviral agents have substantially improved the rate of sustained virologic response and safety in the treatment of hepatitis C. However, concerns about the long-term outcomes for individuals who achieve sustained virologic response still exist. Herein, we propose a new conceptual model for redefining the goals and strategies of ongoing hepatitis C elimination campaigns.
Mehr lesen >>
Weitere Beiträge
MAR
11
Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts
By:
Enkhtuul Batbold
on
MAR
11
Nature Reviews Gastroenterology & Hepatology, Published online: 11 March 2026; doi:10.1038/s41575-026-01186-9The elimination of hepatitis B will not be achieved through innovation alone. It requires dismantling the structural inequities that have long constrained who leads, funds and benefits from global hepatitis B research.
Mehr lesen >>
MAR
09
Physical activity and the gut
By:
Katrina Ray
on
MAR
09
Nature Reviews Gastroenterology & Hepatology, Published online: 09 March 2026; doi:10.1038/s41575-026-01192-xPhysical activity and the gut
Mehr lesen >>
MAR
06
ECCO’26
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01194-9ECCO’26
Mehr lesen >>
MAR
06
Long-term data for ileocaecal resection for ileal Crohn’s disease
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01193-wLong-term data for ileocaecal resection for ileal Crohn’s disease
Mehr lesen >>
MAR
06
HIV-associated gut microbiome influences gut mucosal immunity
By:
Katrina Ray
on
MAR
06
Nature Reviews Gastroenterology & Hepatology, Published online: 06 March 2026; doi:10.1038/s41575-026-01191-yHIV-associated gut microbiome influences gut mucosal immunity
Mehr lesen >>
MAR
04
Microplastics and nanoplastics in the human gut: from signals to standards
By:
Brian D. Deng
on
MAR
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 March 2026; doi:10.1038/s41575-026-01185-wThe gastrointestinal tract is a critical interface for microplastic and nanoplastic exposure, yet causal links to health outcomes remain uncertain. We outline current methodological challenges and provide a list of minimum standards for rigorous study design, standardized reporting and careful attention to interpretations to distinguish mechanism from signals.
Mehr lesen >>
MAR
02
Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut
By:
Shan Liu
on
MAR
02
Nature Reviews Gastroenterology & Hepatology, Published online: 02 March 2026; doi:10.1038/s41575-026-01178-9Metabolites are important mediators of metabolism at the cellular and organismal levels. This Review explores the concept of metabotherapy, harnessing metabolites to prevent and treat gastrointestinal disorders, providing insights into metabolite classifications and their pathophysiological mechanisms in health and disease and mapping their potential as therapeutic targets.
Mehr lesen >>
FEB
23
Hepatitis C elimination: is it time to redefine the goals?
By:
Yasser Fouad
on
FEB
23
Nature Reviews Gastroenterology & Hepatology, Published online: 23 February 2026; doi:10.1038/s41575-026-01184-xDirect-acting antiviral agents have substantially improved the rate of sustained virologic response and safety in the treatment of hepatitis C. However, concerns about the long-term outcomes for individuals who achieve sustained virologic response still exist. Herein, we propose a new conceptual model for redefining the goals and strategies of ongoing hepatitis C elimination campaigns.
Mehr lesen >>
Weitere Beiträge
Nephrologie
MAR
11
‘Missing’ disease-causing variants in Alport syndrome
By:
Judy Savige
on
MAR
11
Nature Reviews Nephrology, Published online: 11 March 2026; doi:10.1038/s41581-026-01061-5Here, the authors discuss explanations for missing disease-causing variants in Alport syndrome, how clinicians and laboratories might manage missing variants and how to care for patients when a clinical suspicion of Alport syndrome exists but no disease-causing variant has been identified.
Mehr lesen >>
MAR
04
Bridging structure and function: artificial intelligence-based modelling of kidney proteins
By:
Sean Wu
on
MAR
04
Nature Reviews Nephrology, Published online: 04 March 2026; doi:10.1038/s41581-026-01060-6Advances in artificial intelligence-driven algorithms and experimental technologies have revolutionized the field of protein modelling. This Review describes how these developments have provided unprecedented insights into the structure of key proteins within the kidney, improved understanding of the relationships between protein structure and stability, and enabled mechanistic interpretation of variants that underlie a variety of kidney pathologies.
Mehr lesen >>
MAR
04
The impact of social determinants of health on acute kidney injury
By:
Samira Bell
on
MAR
04
Nature Reviews Nephrology, Published online: 04 March 2026; doi:10.1038/s41581-026-01063-3Social determinants of health can have a considerable impact on patient outcomes. Here, the authors examine how social determinants of health contribute to the growing global burden of acute kidney injury and its inequities, and discuss key strategies for tackling disparities in acute kidney injury care and outcomes.
Mehr lesen >>
MAR
02
Replenishing methionine protects the host via kidney removal of excess cytokines from blood
By:
Monica Wang
on
MAR
02
Nature Reviews Nephrology, Published online: 02 March 2026; doi:10.1038/s41581-026-01064-2Replenishing methionine protects the host via kidney removal of excess cytokines from blood
Mehr lesen >>
MAR
02
Hepatokine regulation of kidney fibrosis
By:
Susan J. Allison
on
MAR
02
Nature Reviews Nephrology, Published online: 02 March 2026; doi:10.1038/s41581-026-01065-1Hepatokine regulation of kidney fibrosis
Mehr lesen >>
FEB
17
When access outpaces ethics: reflections on dialysis expansion and health system integrity
By:
Yot Teerawattananon
on
FEB
17
Nature Reviews Nephrology, Published online: 17 February 2026; doi:10.1038/s41581-026-01062-4Thailand’s dialysis policy reform, introduced in 2022, aimed to enable universal access to life-sustaining dialysis, but instead exposed systemic vulnerabilities that undermined dialysis quality, compromised patient safety and threatened sustainability of care. These outcomes highlight three ethical dilemmas — access versus quality, continuity of care, and financial conflicts of interest — and offer powerful insights into the ethical tensions that are shaping kidney care globally.
Mehr lesen >>
FEB
16
Graph neural networks for computational nephrology
By:
Michael T. Schaub
on
FEB
16
Nature Reviews Nephrology, Published online: 16 February 2026; doi:10.1038/s41581-026-01059-zGraph neural networks offer a unifying artificial intelligence framework to model related objects, ranging from tissue architecture and geometrical relationships to patient similarity and multi-organ networks. Applications of this technology in nephrology include computational representation of kidney histopathology and modelling of the complex interactions between organs in kidney diseases.
Mehr lesen >>
FEB
10
Optimal patient care in advanced chronic kidney disease progressing to kidney failure
By:
Christian Combe
on
FEB
10
Nature Reviews Nephrology, Published online: 10 February 2026; doi:10.1038/s41581-026-01056-2This Review discusses key strategies for managing patients with advanced chronic kidney disease progressing towards kidney failure. The authors examine drug and lifestyle interventions that can mitigate kidney and cardiovascular risks, and options for addressing kidney failure, including transplantation, dialysis and conservative kidney care, with an emphasis on informed shared decision-making.
Mehr lesen >>
Weitere Beiträge
MAR
11
‘Missing’ disease-causing variants in Alport syndrome
By:
Judy Savige
on
MAR
11
Nature Reviews Nephrology, Published online: 11 March 2026; doi:10.1038/s41581-026-01061-5Here, the authors discuss explanations for missing disease-causing variants in Alport syndrome, how clinicians and laboratories might manage missing variants and how to care for patients when a clinical suspicion of Alport syndrome exists but no disease-causing variant has been identified.
Mehr lesen >>
MAR
04
Bridging structure and function: artificial intelligence-based modelling of kidney proteins
By:
Sean Wu
on
MAR
04
Nature Reviews Nephrology, Published online: 04 March 2026; doi:10.1038/s41581-026-01060-6Advances in artificial intelligence-driven algorithms and experimental technologies have revolutionized the field of protein modelling. This Review describes how these developments have provided unprecedented insights into the structure of key proteins within the kidney, improved understanding of the relationships between protein structure and stability, and enabled mechanistic interpretation of variants that underlie a variety of kidney pathologies.
Mehr lesen >>
MAR
04
The impact of social determinants of health on acute kidney injury
By:
Samira Bell
on
MAR
04
Nature Reviews Nephrology, Published online: 04 March 2026; doi:10.1038/s41581-026-01063-3Social determinants of health can have a considerable impact on patient outcomes. Here, the authors examine how social determinants of health contribute to the growing global burden of acute kidney injury and its inequities, and discuss key strategies for tackling disparities in acute kidney injury care and outcomes.
Mehr lesen >>
MAR
02
Replenishing methionine protects the host via kidney removal of excess cytokines from blood
By:
Monica Wang
on
MAR
02
Nature Reviews Nephrology, Published online: 02 March 2026; doi:10.1038/s41581-026-01064-2Replenishing methionine protects the host via kidney removal of excess cytokines from blood
Mehr lesen >>
MAR
02
Hepatokine regulation of kidney fibrosis
By:
Susan J. Allison
on
MAR
02
Nature Reviews Nephrology, Published online: 02 March 2026; doi:10.1038/s41581-026-01065-1Hepatokine regulation of kidney fibrosis
Mehr lesen >>
FEB
17
When access outpaces ethics: reflections on dialysis expansion and health system integrity
By:
Yot Teerawattananon
on
FEB
17
Nature Reviews Nephrology, Published online: 17 February 2026; doi:10.1038/s41581-026-01062-4Thailand’s dialysis policy reform, introduced in 2022, aimed to enable universal access to life-sustaining dialysis, but instead exposed systemic vulnerabilities that undermined dialysis quality, compromised patient safety and threatened sustainability of care. These outcomes highlight three ethical dilemmas — access versus quality, continuity of care, and financial conflicts of interest — and offer powerful insights into the ethical tensions that are shaping kidney care globally.
Mehr lesen >>
FEB
16
Graph neural networks for computational nephrology
By:
Michael T. Schaub
on
FEB
16
Nature Reviews Nephrology, Published online: 16 February 2026; doi:10.1038/s41581-026-01059-zGraph neural networks offer a unifying artificial intelligence framework to model related objects, ranging from tissue architecture and geometrical relationships to patient similarity and multi-organ networks. Applications of this technology in nephrology include computational representation of kidney histopathology and modelling of the complex interactions between organs in kidney diseases.
Mehr lesen >>
FEB
10
Optimal patient care in advanced chronic kidney disease progressing to kidney failure
By:
Christian Combe
on
FEB
10
Nature Reviews Nephrology, Published online: 10 February 2026; doi:10.1038/s41581-026-01056-2This Review discusses key strategies for managing patients with advanced chronic kidney disease progressing towards kidney failure. The authors examine drug and lifestyle interventions that can mitigate kidney and cardiovascular risks, and options for addressing kidney failure, including transplantation, dialysis and conservative kidney care, with an emphasis on informed shared decision-making.
Mehr lesen >>
Weitere Beiträge
Neurologie
MAR
11
Deconstruction of a memory engram reveals distinct ensembles recruited at learning
By:
Clément Pouget
on
MAR
11
Nature Neuroscience, Published online: 11 March 2026; doi:10.1038/s41593-026-02230-2Pouget et al. identified distinct CA1 neuron ensembles active during specific moments of fear learning and uncovered the core engram essential for memory formation.
Mehr lesen >>
MAR
11
Competitive interactions shape mammalian brain network dynamics and computation
By:
Andrea I. Luppi
on
MAR
11
Nature Neuroscience, Published online: 11 March 2026; doi:10.1038/s41593-026-02205-3Brain network architecture may balance cooperation and competition across circuits. Here the authors use computational whole-brain modeling across three species to show that models with competition are more realistic, more personalized and perform better.
Mehr lesen >>
MAR
10
Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos
By:
Jackson W. Mace
on
MAR
10
Nature Neuroscience, Published online: 10 March 2026; doi:10.1038/s41593-026-02246-8Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos
Mehr lesen >>
MAR
10
Persistent interferon signaling causes sensory neuron plasticity and pain before and during arthritis
By:
Jie Su
on
MAR
10
Nature Neuroscience, Published online: 10 March 2026; doi:10.1038/s41593-026-02234-ySu et al. show that inflammatory arthritis pain stems from sustained interferon-driven MNK1/MNK2–elF4E signaling that sensitizes joint-innervating neurons. Blocking this pathway reverses pain, suggesting a targeted therapeutic strategy.
Mehr lesen >>
MAR
10
Neuronal tuning aligns dynamically with object and texture manifolds across the visual hierarchy
By:
Binxu Wang
on
MAR
10
Nature Neuroscience, Published online: 10 March 2026; doi:10.1038/s41593-026-02207-1Visual neurons drive two AI models to compete in generating neuron-preferred features. The models form shared local motifs, while neuronal preference shifts from texture to object structure over time, revealing dynamic changes in visual coding.
Mehr lesen >>
MAR
09
How the brain can harm the heart
By:
Leonie Welberg
on
MAR
09
Nature Neuroscience, Published online: 09 March 2026; doi:10.1038/s41593-026-02243-xHow the brain can harm the heart
Mehr lesen >>
MAR
09
Liver-derived exercise factor boosts brain vasculature
By:
Rebecca Wright
on
MAR
09
Nature Neuroscience, Published online: 09 March 2026; doi:10.1038/s41593-026-02241-zLiver-derived exercise factor boosts brain vasculature
Mehr lesen >>
MAR
09
A year in the brain
By:
William P. Olson
on
MAR
09
Nature Neuroscience, Published online: 09 March 2026; doi:10.1038/s41593-026-02244-wA year in the brain
Mehr lesen >>
Weitere Beiträge
MAR
11
Tsunamis hiding in plain sight: spreading depression in clinical neurology
By:
Cenk Ayata
on
MAR
11
Nature Reviews Neurology, Published online: 11 March 2026; doi:10.1038/s41582-026-01191-1Spreading depression is a slowly propagating wave of mass depolarization that successively engulfs contiguous brain regions, causing transient neuronal hyperexcitability at its leading edge, followed by complete but reversible neuronal silence lasting minutes. Here, the authors present an evidence-based view of spreading depression as a probable cause of characteristic neurological signs and symptoms in numerous neurological conditions.
Mehr lesen >>
MAR
10
Modelling brain tumours with organoids: towards precision medicine in neuro-oncology
By:
Marta de Lucas Sanz
on
MAR
10
Nature Reviews Neurology, Published online: 10 March 2026; doi:10.1038/s41582-026-01190-2Organoids provide a useful model to capture the heterogeneity of brain tumours. Here, the authors assess current methodologies for generating organoids from various types of brain tumour and discuss how these models have enhanced mechanistic insight into tumour initiation, progression and resistance to treatment, moving towards precision medicine.
Mehr lesen >>
MAR
05
We need to talk about risk in multiple sclerosis
By:
Beth Grimsey
on
MAR
05
Nature Reviews Neurology, Published online: 05 March 2026; doi:10.1038/s41582-026-01182-2Beth Grimsey lives with relapsing–remitting multiple sclerosis (MS) and is the Research Programme Manager at the MS Society in the UK. In this World View, she reflects on the uncertainty of MS, the ripple effects in families and the need for healthcare providers to communicate the knowns and unknowns.
Mehr lesen >>
MAR
04
Epidemiological principles behind worldwide growth of Parkinson disease — a bathtub analogy
By:
Lisanne J. Dommershuijsen
on
MAR
04
Nature Reviews Neurology, Published online: 04 March 2026; doi:10.1038/s41582-026-01193-zParkinson disease (PD) is the fastest growing neurodegenerative condition worldwide, and proposed explanations for this growth include ageing, increased environmental exposures and better recognition. Using an adaptation of the classical epidemiological bathtub as a metaphor, we consider the potential contributions of epidemiological dynamics to the growth in PD and their implications for PD research.
Mehr lesen >>
FEB
13
Towards biomarker-based diagnosis of Parkinson disease
By:
Eduardo Tolosa
on
FEB
13
Nature Reviews Neurology, Published online: 13 February 2026; doi:10.1038/s41582-026-01185-zClinical diagnostic criteria for Parkinson disease (PD) have limitations, but no validated biomarker-based diagnostic framework currently exists. In this Review, Tolosa et al. examine progress towards biomarker-based diagnosis of PD, focusing on α-synuclein seed amplification assays alongside molecular, imaging and genetic markers.
Mehr lesen >>
FEB
11
Immune gateways bypass blood–brain barrier for drug delivery in stroke
By:
Lisa Kiani
on
FEB
11
Nature Reviews Neurology, Published online: 11 February 2026; doi:10.1038/s41582-026-01188-wThe natural migration pathway of CNS immune cells can be harnessed to deliver therapy to brain lesions in acute stroke, bypassing the blood–brain barrier (BBB), according to a new study published in Cell.
Mehr lesen >>
FEB
11
Recalled experiences of death: need for empirical research without prejudice
By:
Sam Parnia
on
FEB
11
Nature Reviews Neurology, Published online: 11 February 2026; doi:10.1038/s41582-026-01186-yRecalled experiences of death: need for empirical research without prejudice
Mehr lesen >>
FEB
11
Reply to ‘Recalled experiences of death: need for empirical research without prejudice’
By:
Pauline Fritz
on
FEB
11
Nature Reviews Neurology, Published online: 11 February 2026; doi:10.1038/s41582-026-01187-xReply to ‘Recalled experiences of death: need for empirical research without prejudice’
Mehr lesen >>
Weitere Beiträge
Rheumatologie
MAR
02
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis
By:
Lilla Gunkl-Tóth
on
MAR
02
Nature Reviews Rheumatology, Published online: 02 March 2026; doi:10.1038/s41584-026-01354-wIn this Perspective, the authors discuss how integrating difficult-to-treat into the treat-to-target strategy could improve outcomes for those patients with rheumatoid arthritis who do not follow the standard treat-to-target trajectory. The proposed strategy is aimed at providing a more personalized approach to disease management for those patients with difficult-to-treat disease.
Mehr lesen >>
MAR
02
Neurodevelopmental comorbidities in juvenile systemic autoimmune and autoinflammatory diseases
By:
Pierre Ellul
on
MAR
02
Nature Reviews Rheumatology, Published online: 02 March 2026; doi:10.1038/s41584-026-01356-8Neurodevelopmental disorders frequently co-occur with juvenile systemic autoimmune and autoinflammatory diseases, driven by immune–neurodevelopmental interactions. Early screening, multidisciplinary care and personalized interventions are essential, alongside research into mechanisms, biomarkers and long-term outcomes to improve education, psychosocial wellbeing and quality of life.
Mehr lesen >>
FEB
26
Identifying fibromyalgia phenotypes based on psychological symptom burden
By:
Ana Margarida Pinto
on
FEB
26
Nature Reviews Rheumatology, Published online: 26 February 2026; doi:10.1038/s41584-026-01362-wPsychological symptoms have a pivotal role in determining the severity of fibromyalgia. Findings now show that identifying and managing these symptoms during the early stages of disease could reveal disease phenotypes and improve the management of fibromyalgia.
Mehr lesen >>
FEB
25
What rheumatology can learn from oncology: a patient’s perspective
By:
Sarah Sisbot
on
FEB
25
Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01364-8Drawing on my contrasting experiences as a patient in oncology and rheumatology, I have seen how the lack of precision-based diagnostics and meaningful endpoints limits progress in rheumatic disease. I believe biologically grounded classification systems and greater patient involvement are essential for more effective and responsive care.
Mehr lesen >>
FEB
25
Metabolic masqueraders of paediatric and adult rheumatic diseases
By:
Steven H. Lang
on
FEB
25
Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01352-yInborn errors of metabolism are a diverse group of disorders that can mimic rheumatological disease, often presenting with progressive joint and systemic involvement. This Review serves as a primer for rheumatologists, covering clinical aspects and potential mechanisms by which these metabolic alterations cause immune dysregulation.
Mehr lesen >>
FEB
16
Author Correction: Inflammation and pain as interconnected targets in axial spondyloarthritis
By:
Xenofon Baraliakos
on
FEB
16
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01363-9Author Correction: Inflammation and pain as interconnected targets in axial spondyloarthritis
Mehr lesen >>
FEB
16
Immune reset and immune retune: approaching cure?
By:
John D. Isaacs
on
FEB
16
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01357-7The emergence of potent depletion therapies for the treatment of refractory autoimmunity has led to the concept of immune reset. Understanding whether immune reset equates to cure, and whether cure is achievable through non-depleting approaches, depends on the identification of immune biomarkers for measuring healthy and pathological immunity.
Mehr lesen >>
FEB
10
Vagus nerve stimulation shows clinical benefits for RA in pivotal trial
By:
Sarah Onuora
on
FEB
10
Nature Reviews Rheumatology, Published online: 10 February 2026; doi:10.1038/s41584-026-01359-5The findings of the pivotal RESET-RA trial demonstrate the clinical benefits and safety of an implanted neuromodulation device that stimulates the vagus nerve for the treatment of rheumatoid arthritis.
Mehr lesen >>
Weitere Beiträge
MAR
02
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis
By:
Lilla Gunkl-Tóth
on
MAR
02
Nature Reviews Rheumatology, Published online: 02 March 2026; doi:10.1038/s41584-026-01354-wIn this Perspective, the authors discuss how integrating difficult-to-treat into the treat-to-target strategy could improve outcomes for those patients with rheumatoid arthritis who do not follow the standard treat-to-target trajectory. The proposed strategy is aimed at providing a more personalized approach to disease management for those patients with difficult-to-treat disease.
Mehr lesen >>
MAR
02
Neurodevelopmental comorbidities in juvenile systemic autoimmune and autoinflammatory diseases
By:
Pierre Ellul
on
MAR
02
Nature Reviews Rheumatology, Published online: 02 March 2026; doi:10.1038/s41584-026-01356-8Neurodevelopmental disorders frequently co-occur with juvenile systemic autoimmune and autoinflammatory diseases, driven by immune–neurodevelopmental interactions. Early screening, multidisciplinary care and personalized interventions are essential, alongside research into mechanisms, biomarkers and long-term outcomes to improve education, psychosocial wellbeing and quality of life.
Mehr lesen >>
FEB
26
Identifying fibromyalgia phenotypes based on psychological symptom burden
By:
Ana Margarida Pinto
on
FEB
26
Nature Reviews Rheumatology, Published online: 26 February 2026; doi:10.1038/s41584-026-01362-wPsychological symptoms have a pivotal role in determining the severity of fibromyalgia. Findings now show that identifying and managing these symptoms during the early stages of disease could reveal disease phenotypes and improve the management of fibromyalgia.
Mehr lesen >>
FEB
25
What rheumatology can learn from oncology: a patient’s perspective
By:
Sarah Sisbot
on
FEB
25
Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01364-8Drawing on my contrasting experiences as a patient in oncology and rheumatology, I have seen how the lack of precision-based diagnostics and meaningful endpoints limits progress in rheumatic disease. I believe biologically grounded classification systems and greater patient involvement are essential for more effective and responsive care.
Mehr lesen >>
FEB
25
Metabolic masqueraders of paediatric and adult rheumatic diseases
By:
Steven H. Lang
on
FEB
25
Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01352-yInborn errors of metabolism are a diverse group of disorders that can mimic rheumatological disease, often presenting with progressive joint and systemic involvement. This Review serves as a primer for rheumatologists, covering clinical aspects and potential mechanisms by which these metabolic alterations cause immune dysregulation.
Mehr lesen >>
FEB
16
Author Correction: Inflammation and pain as interconnected targets in axial spondyloarthritis
By:
Xenofon Baraliakos
on
FEB
16
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01363-9Author Correction: Inflammation and pain as interconnected targets in axial spondyloarthritis
Mehr lesen >>
FEB
16
Immune reset and immune retune: approaching cure?
By:
John D. Isaacs
on
FEB
16
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01357-7The emergence of potent depletion therapies for the treatment of refractory autoimmunity has led to the concept of immune reset. Understanding whether immune reset equates to cure, and whether cure is achievable through non-depleting approaches, depends on the identification of immune biomarkers for measuring healthy and pathological immunity.
Mehr lesen >>
FEB
10
Vagus nerve stimulation shows clinical benefits for RA in pivotal trial
By:
Sarah Onuora
on
FEB
10
Nature Reviews Rheumatology, Published online: 10 February 2026; doi:10.1038/s41584-026-01359-5The findings of the pivotal RESET-RA trial demonstrate the clinical benefits and safety of an implanted neuromodulation device that stimulates the vagus nerve for the treatment of rheumatoid arthritis.
Mehr lesen >>
Weitere Beiträge
Urologie
MAR
06
Prostate cancer screening: weighing the benefits and harms
By:
Nikhil Mayor
on
MAR
06
Nature Reviews Urology, Published online: 06 March 2026; doi:10.1038/s41585-026-01133-yThe UK’s National Screening Committee recently recommended against population-level prostate cancer screening. Calls to override this guidance are intensifying, but acting without robust evidence might risk exposing thousands of men to unnecessary harm. Data-driven policy changes are crucial.
Mehr lesen >>
MAR
04
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia
By:
Emilie Elmelund
on
MAR
04
Nature Reviews Urology, Published online: 04 March 2026; doi:10.1038/s41585-026-01132-zThis Perspective presents historical and emerging evidence supporting a role of oestrogen signalling in male sexual differentiation, challenging the traditional androgen-centric view of reproductive development. Understanding the interplay between these two hormones is important to understanding development and also chemical risk, considering the susceptibility of these systems to disruption from exogenous substances.
Mehr lesen >>
FEB
26
Urinary tract infections in children
By:
Preeti P. John
on
FEB
26
Nature Reviews Urology, Published online: 26 February 2026; doi:10.1038/s41585-026-01130-1In this Review, the authors describe and discuss the unique challenges of paediatric urinary tract infections including diagnosis, prevention and management, potential for adverse sequelae and key knowledge gaps.
Mehr lesen >>
FEB
13
Smooth muscle cell plasticity in pelvic organ prolapse
By:
Hai Tong
on
FEB
13
Nature Reviews Urology, Published online: 13 February 2026; doi:10.1038/s41585-026-01131-0Vaginal wall smooth muscle underpins pelvic support. In pelvic organ prolapse, smooth muscle cells are depleted and shift from a contractile phenotype to remodelling programmes, paralleling stress-induced switching in vascular disease. Defining trajectories and drivers could yield biomarkers and translatable, locally deliverable therapies to curb progression and recurrence.
Mehr lesen >>
FEB
09
ADT and activation of HGF and WNT axes in double-null prostate cancer
By:
Dexter Hoi Long Leung
on
FEB
09
Nature Reviews Urology, Published online: 09 February 2026; doi:10.1038/s41585-026-01129-8In this Review, the authors discuss the causal role of current androgen deprivation therapy in prostate cancer progression, hormone refractoriness and double-null prostate cancer development. They highlight the underlying regulatory mechanisms by which androgen deprivation therapy elevates hepatocyte growth factor–hepatocyte growth factor receptor (HGF–MET) and WNT–β-catenin signalling, elevating exportin 1 (XPO1) and ribosomal protein activation to induce tumour aggressiveness, metastasis and double-null prostate cancer development.
Mehr lesen >>
FEB
05
Leveraging generative AI to enhance doctor–patient communication
By:
Aalamnoor S. Pannu
on
FEB
05
Nature Reviews Urology, Published online: 05 February 2026; doi:10.1038/s41585-026-01127-wGenerative artificial intelligence (GAI) can produce high-quality lay summaries of medical literature, clinical trial information and guideline-based materials that meet recommended reading levels while preserving scientific integrity. Although important limitations remain, with appropriate safeguards, GAI has the potential to bridge longstanding gaps between certified medical knowledge and patient understanding.
Mehr lesen >>
FEB
04
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health
By:
Sergio Pecorelli
on
FEB
04
Nature Reviews Urology, Published online: 04 February 2026; doi:10.1038/s41585-026-01128-9Historically, the contribution of fathers to offspring health has been neglected, with the focus on mothers. However, growing evidence shows the important influence that the environmental factors the fathers experience has on sperm epigenetics and, consequently, the health of the next generation.
Mehr lesen >>
JAN
30
Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy
By:
Elizabeth Day
on
JAN
30
Nature Reviews Urology, Published online: 30 January 2026; doi:10.1038/s41585-026-01124-zSurgical menopause occurs in premenopausal women who undergo radical cystectomy with bilateral oophorectomy to treat bladder cancer. This Review discusses the pathophysiology of surgical menopause in these patients and highlights current strategies to mitigate associated symptoms and long-term health risks.
Mehr lesen >>
Weitere Beiträge
MAR
06
Prostate cancer screening: weighing the benefits and harms
By:
Nikhil Mayor
on
MAR
06
Nature Reviews Urology, Published online: 06 March 2026; doi:10.1038/s41585-026-01133-yThe UK’s National Screening Committee recently recommended against population-level prostate cancer screening. Calls to override this guidance are intensifying, but acting without robust evidence might risk exposing thousands of men to unnecessary harm. Data-driven policy changes are crucial.
Mehr lesen >>
MAR
04
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia
By:
Emilie Elmelund
on
MAR
04
Nature Reviews Urology, Published online: 04 March 2026; doi:10.1038/s41585-026-01132-zThis Perspective presents historical and emerging evidence supporting a role of oestrogen signalling in male sexual differentiation, challenging the traditional androgen-centric view of reproductive development. Understanding the interplay between these two hormones is important to understanding development and also chemical risk, considering the susceptibility of these systems to disruption from exogenous substances.
Mehr lesen >>
FEB
26
Urinary tract infections in children
By:
Preeti P. John
on
FEB
26
Nature Reviews Urology, Published online: 26 February 2026; doi:10.1038/s41585-026-01130-1In this Review, the authors describe and discuss the unique challenges of paediatric urinary tract infections including diagnosis, prevention and management, potential for adverse sequelae and key knowledge gaps.
Mehr lesen >>
FEB
13
Smooth muscle cell plasticity in pelvic organ prolapse
By:
Hai Tong
on
FEB
13
Nature Reviews Urology, Published online: 13 February 2026; doi:10.1038/s41585-026-01131-0Vaginal wall smooth muscle underpins pelvic support. In pelvic organ prolapse, smooth muscle cells are depleted and shift from a contractile phenotype to remodelling programmes, paralleling stress-induced switching in vascular disease. Defining trajectories and drivers could yield biomarkers and translatable, locally deliverable therapies to curb progression and recurrence.
Mehr lesen >>
FEB
09
ADT and activation of HGF and WNT axes in double-null prostate cancer
By:
Dexter Hoi Long Leung
on
FEB
09
Nature Reviews Urology, Published online: 09 February 2026; doi:10.1038/s41585-026-01129-8In this Review, the authors discuss the causal role of current androgen deprivation therapy in prostate cancer progression, hormone refractoriness and double-null prostate cancer development. They highlight the underlying regulatory mechanisms by which androgen deprivation therapy elevates hepatocyte growth factor–hepatocyte growth factor receptor (HGF–MET) and WNT–β-catenin signalling, elevating exportin 1 (XPO1) and ribosomal protein activation to induce tumour aggressiveness, metastasis and double-null prostate cancer development.
Mehr lesen >>
FEB
05
Leveraging generative AI to enhance doctor–patient communication
By:
Aalamnoor S. Pannu
on
FEB
05
Nature Reviews Urology, Published online: 05 February 2026; doi:10.1038/s41585-026-01127-wGenerative artificial intelligence (GAI) can produce high-quality lay summaries of medical literature, clinical trial information and guideline-based materials that meet recommended reading levels while preserving scientific integrity. Although important limitations remain, with appropriate safeguards, GAI has the potential to bridge longstanding gaps between certified medical knowledge and patient understanding.
Mehr lesen >>
FEB
04
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health
By:
Sergio Pecorelli
on
FEB
04
Nature Reviews Urology, Published online: 04 February 2026; doi:10.1038/s41585-026-01128-9Historically, the contribution of fathers to offspring health has been neglected, with the focus on mothers. However, growing evidence shows the important influence that the environmental factors the fathers experience has on sperm epigenetics and, consequently, the health of the next generation.
Mehr lesen >>
JAN
30
Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy
By:
Elizabeth Day
on
JAN
30
Nature Reviews Urology, Published online: 30 January 2026; doi:10.1038/s41585-026-01124-zSurgical menopause occurs in premenopausal women who undergo radical cystectomy with bilateral oophorectomy to treat bladder cancer. This Review discusses the pathophysiology of surgical menopause in these patients and highlights current strategies to mitigate associated symptoms and long-term health risks.
Mehr lesen >>
Weitere Beiträge
Newsletter
Share by: